|
|
||||||||
Biology of Reproduction, Vol 57, 1285-1292, Copyright © 1997 by Society for the Study of Reproduction
ARTICLES |
KI Dibbs, E Anteby, MA Mallon, Y Sadovsky and S Adler
Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
The mechanism of labor initiation in humans has not been completely elucidated. Prostaglandins, estrogens, and corticotropin-releasing factor (CRF) have all been shown to affect uterine myocytes and enhance uterine contractility. There are also indications that these uterine regulators have additional effects on other sites involved in labor and that they may act in concert or, perhaps, by regulating each other. Therefore, we evaluated the CRF promoter for transcriptional regulation by prostaglandins and estrogens. Human placental choriocarcinoma cell lines were transfected with CRF-luciferase reporter genes and treated with prostaglandins. Prostaglandin E2 (PGE2), but not prostaglandin F2alpha (PGF2alpha), stimulated CRF-luciferase expression in choriocarcinoma cell lines via a cAMP-dependent pathway. A combination of transfections and in vitro binding studies tested for potential regulation of CRF by estrogen receptor (ER). ER neither regulated the CRF promoter nor interacted with steroid response half-sites from the CRF promoter. Our results provide a molecular regulatory link between PGE2 and CRF, two compounds that enhance uterine contractile function. Combined with the stimulation of prostaglandin release by CRF, these data support a potentially important "feed-forward" regulatory loop involving CRF and PGE2 in parturition. In contrast, we found no evidence for direct effects of estrogens or PGF2alpha on CRF transcription.
This article has been cited by other articles:
![]() |
A. S. Lalmansingh and R. M. Uht Estradiol Regulates Corticotropin-Releasing Hormone Gene (crh) Expression in a Rapid and Phasic Manner that Parallels Estrogen Receptor-{alpha} and - Recruitment to a 3',5'-Cyclic Adenosine 5'-Monophosphate Regulatory Region of the Proximal crh Promoter Endocrinology, January 1, 2008; 149(1): 346 - 357. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Florio, P J Lowry, C Benedetto, L Galleri, M Torricelli, A Giovannelli, R Battista, F M Reis, and F Petraglia Maternal plasma corticotropin-releasing factor (CRF) and CRF-binding protein (CRF-BP) levels in post-term pregnancy: effect of prostaglandin administration Eur. J. Endocrinol., September 1, 2007; 157(3): 279 - 284. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Ni, Y. Hou, B. R. King, X. Tang, M. A. Read, R. Smith, and R. C. Nicholson Estrogen Receptor-Mediated Down-Regulation of Corticotropin-Releasing Hormone Gene Expression Is Dependent on a Cyclic Adenosine 3',5'-Monophosphate Regulatory Element in Human Placental Syncytiotrophoblast Cells J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2312 - 2318. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Ni, R. C. Nicholson, B. R. King, E.-C. Chan, M. A. Read, and R. Smith Estrogen Represses whereas the Estrogen-Antagonist ICI 182780 Stimulates Placental CRH Gene Expression J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3774 - 3778. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ramkumar and S. Adler A Requirement for the POU Transcription Factor, Brn-2, in Corticotropin-Releasing Hormone Expression in a Neuronal Cell Line Mol. Endocrinol., August 1, 1999; 13(8): 1237 - 1248. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |